USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Malapelle U, Morra F, Ilardi G, Visconti R, Merolla F, Cerrato A, Napolitano V, Monaco R, Guggino G, Monaco G, Staibano S, Troncone G, Celetti A.
Malapelle U, et al. Among authors: monaco g, monaco r.
Lung Cancer. 2017 May;107:41-49. doi: 10.1016/j.lungcan.2016.06.015. Epub 2016 Jun 17.
Lung Cancer. 2017.
PMID: 27372520